Cargando…

Percutaneous Placement of Self-Expandable Metallic Stents in Patients with Obstructive Jaundice Secondary to Metastatic Gastric Cancer after Gastrectomy

OBJECTIVE: To evaluate the outcomes of patients undergoing percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. MATERIALS AND METHODS: Fifty patients (mean age, 62.4 years; range, 27-86 years) who underwent percutaneous placeme...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Hyun Pyo, Seo, Tae-Seok, Cha, In-Ho, Yu, Jung Rim, Mok, Young Jae, Oh, Joo Hyeong, Kwon, Se Hwan, Kim, Sam Soo, Kim, Seung Kwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772260/
https://www.ncbi.nlm.nih.gov/pubmed/24043974
http://dx.doi.org/10.3348/kjr.2013.14.5.789
_version_ 1782284300294553600
author Hong, Hyun Pyo
Seo, Tae-Seok
Cha, In-Ho
Yu, Jung Rim
Mok, Young Jae
Oh, Joo Hyeong
Kwon, Se Hwan
Kim, Sam Soo
Kim, Seung Kwon
author_facet Hong, Hyun Pyo
Seo, Tae-Seok
Cha, In-Ho
Yu, Jung Rim
Mok, Young Jae
Oh, Joo Hyeong
Kwon, Se Hwan
Kim, Sam Soo
Kim, Seung Kwon
author_sort Hong, Hyun Pyo
collection PubMed
description OBJECTIVE: To evaluate the outcomes of patients undergoing percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. MATERIALS AND METHODS: Fifty patients (mean age, 62.4 years; range, 27-86 years) who underwent percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy were included. The technical success rate, clinical success rate, complication rate, stent patency, patient survival and factors associated with stent patency were being evaluated. RESULTS: The median interval between the gastrectomy and stent placement was 23.1 months (range, 3.9-94.6 months). The 50 patients received a total of 65 stents without any major procedure-related complications. Technical success was achieved in all patients. The mean total serum bilirubin level, which had been 7.19 mg/dL ± 6.8 before stent insertion, decreased to 4.58 mg/dL ± 5.4 during the first week of follow-up (p < 0.001). Clinical success was achieved in 42 patients (84%). Percutaneous transhepatic biliary drainage catheters were removed from 45 patients (90%). Infectious complications were noted in two patients (4%), and stent malfunction occurred in seven patients (14%). The median stent patency was 233 ± 99 days, and the median patient survival was 179 ± 83 days. Total serum bilirubin level after stenting was an independent factor for stent patency (p = 0.009). CONCLUSION: Percutaneous transhepatic placement of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy is a technically feasible and clinically effective palliative procedure.
format Online
Article
Text
id pubmed-3772260
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Korean Society of Radiology
record_format MEDLINE/PubMed
spelling pubmed-37722602013-09-16 Percutaneous Placement of Self-Expandable Metallic Stents in Patients with Obstructive Jaundice Secondary to Metastatic Gastric Cancer after Gastrectomy Hong, Hyun Pyo Seo, Tae-Seok Cha, In-Ho Yu, Jung Rim Mok, Young Jae Oh, Joo Hyeong Kwon, Se Hwan Kim, Sam Soo Kim, Seung Kwon Korean J Radiol Intervention OBJECTIVE: To evaluate the outcomes of patients undergoing percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. MATERIALS AND METHODS: Fifty patients (mean age, 62.4 years; range, 27-86 years) who underwent percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy were included. The technical success rate, clinical success rate, complication rate, stent patency, patient survival and factors associated with stent patency were being evaluated. RESULTS: The median interval between the gastrectomy and stent placement was 23.1 months (range, 3.9-94.6 months). The 50 patients received a total of 65 stents without any major procedure-related complications. Technical success was achieved in all patients. The mean total serum bilirubin level, which had been 7.19 mg/dL ± 6.8 before stent insertion, decreased to 4.58 mg/dL ± 5.4 during the first week of follow-up (p < 0.001). Clinical success was achieved in 42 patients (84%). Percutaneous transhepatic biliary drainage catheters were removed from 45 patients (90%). Infectious complications were noted in two patients (4%), and stent malfunction occurred in seven patients (14%). The median stent patency was 233 ± 99 days, and the median patient survival was 179 ± 83 days. Total serum bilirubin level after stenting was an independent factor for stent patency (p = 0.009). CONCLUSION: Percutaneous transhepatic placement of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy is a technically feasible and clinically effective palliative procedure. The Korean Society of Radiology 2013 2013-08-30 /pmc/articles/PMC3772260/ /pubmed/24043974 http://dx.doi.org/10.3348/kjr.2013.14.5.789 Text en Copyright © 2013 The Korean Society of Radiology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Intervention
Hong, Hyun Pyo
Seo, Tae-Seok
Cha, In-Ho
Yu, Jung Rim
Mok, Young Jae
Oh, Joo Hyeong
Kwon, Se Hwan
Kim, Sam Soo
Kim, Seung Kwon
Percutaneous Placement of Self-Expandable Metallic Stents in Patients with Obstructive Jaundice Secondary to Metastatic Gastric Cancer after Gastrectomy
title Percutaneous Placement of Self-Expandable Metallic Stents in Patients with Obstructive Jaundice Secondary to Metastatic Gastric Cancer after Gastrectomy
title_full Percutaneous Placement of Self-Expandable Metallic Stents in Patients with Obstructive Jaundice Secondary to Metastatic Gastric Cancer after Gastrectomy
title_fullStr Percutaneous Placement of Self-Expandable Metallic Stents in Patients with Obstructive Jaundice Secondary to Metastatic Gastric Cancer after Gastrectomy
title_full_unstemmed Percutaneous Placement of Self-Expandable Metallic Stents in Patients with Obstructive Jaundice Secondary to Metastatic Gastric Cancer after Gastrectomy
title_short Percutaneous Placement of Self-Expandable Metallic Stents in Patients with Obstructive Jaundice Secondary to Metastatic Gastric Cancer after Gastrectomy
title_sort percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice secondary to metastatic gastric cancer after gastrectomy
topic Intervention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772260/
https://www.ncbi.nlm.nih.gov/pubmed/24043974
http://dx.doi.org/10.3348/kjr.2013.14.5.789
work_keys_str_mv AT honghyunpyo percutaneousplacementofselfexpandablemetallicstentsinpatientswithobstructivejaundicesecondarytometastaticgastriccanceraftergastrectomy
AT seotaeseok percutaneousplacementofselfexpandablemetallicstentsinpatientswithobstructivejaundicesecondarytometastaticgastriccanceraftergastrectomy
AT chainho percutaneousplacementofselfexpandablemetallicstentsinpatientswithobstructivejaundicesecondarytometastaticgastriccanceraftergastrectomy
AT yujungrim percutaneousplacementofselfexpandablemetallicstentsinpatientswithobstructivejaundicesecondarytometastaticgastriccanceraftergastrectomy
AT mokyoungjae percutaneousplacementofselfexpandablemetallicstentsinpatientswithobstructivejaundicesecondarytometastaticgastriccanceraftergastrectomy
AT ohjoohyeong percutaneousplacementofselfexpandablemetallicstentsinpatientswithobstructivejaundicesecondarytometastaticgastriccanceraftergastrectomy
AT kwonsehwan percutaneousplacementofselfexpandablemetallicstentsinpatientswithobstructivejaundicesecondarytometastaticgastriccanceraftergastrectomy
AT kimsamsoo percutaneousplacementofselfexpandablemetallicstentsinpatientswithobstructivejaundicesecondarytometastaticgastriccanceraftergastrectomy
AT kimseungkwon percutaneousplacementofselfexpandablemetallicstentsinpatientswithobstructivejaundicesecondarytometastaticgastriccanceraftergastrectomy